Chapter

Commentary on Part III Developmental Outcomes and Clinical Perspectives

Lynne Henderson and Philip G. Zimbardo

in Extreme Fear, Shyness, and Social Phobia

Published in print October 1999 | ISBN: 9780195118872
Published online March 2012 | e-ISBN: 9780199848232 | DOI: http://dx.doi.org/10.1093/acprof:oso/9780195118872.003.0016

Series: Series in Affective Science

Commentary on Part III Developmental Outcomes and Clinical Perspectives

Show Summary Details

Preview

This chapter addresses the treatment of social phobia and compares and contrasts it with the treatment of panic disorder. It also reports the most current methods for treating shyness and anxiety-related problems in children and adults. Although most studies so far have not determined corticotropin-releasing factor (CRF) and hypothalamic-pituitary-adrenocortical (HPA) axis abnormalities in social phobia, results from animal studies and from human studies of fear and behavioral inhibition indicate that more work is important to clarify the functioning of this system. In general, the data on treatment of social phobia and panic disorder indicates similarities and differences between the two disorders. Both social phobia and panic disorder have been shown to be responsive to several classes of medications. However tricyclic antidepressants are highly effective for panic but disappointing for social phobia.

Keywords: fear; shyness; social phobia; children; adult; panic disorder; behavioral inhibition; trycyclic antidepressants; anxiety

Chapter.  6014 words. 

Subjects: Clinical Psychology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.